Getinge (OTCMKTS:GNGBY) Hits New 1-Year High – Still a Buy?

Getinge (OTCMKTS:GNGBYGet Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $24.67 and last traded at $24.67, with a volume of 167 shares traded. The stock had previously closed at $24.25.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Getinge from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Strong Buy”.

View Our Latest Research Report on Getinge

Getinge Stock Up 0.2%

The firm has a market capitalization of $6.72 billion, a P/E ratio of 23.50 and a beta of 0.96. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 1.31. The stock has a 50 day moving average of $21.21 and a 200-day moving average of $21.33.

Getinge (OTCMKTS:GNGBYGet Free Report) last announced its quarterly earnings results on Friday, July 17th. The company reported $0.38 EPS for the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.12%. The company had revenue of $894.87 million for the quarter. Research analysts predict that Getinge will post 1.38 earnings per share for the current fiscal year.

Getinge Company Profile

(Get Free Report)

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.

Read More

Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.